p53, Bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis.
Astudillo
Horacio
H
Unidad de Investigacion Medica en Enfermedades Oncologicas, Hospital de Oncologia, CMN Siglo XXI, IMSS, CP 06720, Mexico. hastud2@aol.com
Lopez
Tezcatlipoca
T
Castillo
Sebastian
S
Gariglio
Patricio
P
Benitez
Luis
L
D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000473:pathology; D002584:Cervix Uteri / Q000166:cytology / Q000502:physiology; D004847:Epithelial Cells / Q000166:cytology / Q000502:physiology; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D018809:Proliferating Cell Nuclear Antigen / Q000235:genetics*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics*; D012016:Reference Values; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000473:pathology
D018809:Proliferating Cell Nuclear Antigen; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53